Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Operating Officer

SVP, Head of Finance & Admin.

CEO & President

Chief Scientific Officer

Chief Business Officer

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetica...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-12	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-11	Premium	sold	Premium	Premium	Premium	SVP, Head of Finance & Admin.
2024-03-11	Premium	sold	Premium	Premium	Premium	CEO & President
2024-03-11	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	CEO & President
2024-03-11	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-03-08	Premium	sold	Premium	Premium	Premium	SVP, Head of Finance & Admin.
2024-03-08	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-08	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-03-08	Premium	acquired	Premium	Premium	Premium	CEO & President
2024-03-08	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-03-08	Premium	sold	Premium	Premium	Premium	CEO & President
2024-03-08	Premium	acquired	Premium	Premium	Premium	SVP, Head of Finance & Admin.
2024-03-07	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	SVP, Head of Finance & Admin.
2024-03-07	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	CEO & President
2024-03-01	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-03-01	Premium	acquired	Premium	Premium	Premium	CEO & President
2024-03-01	Premium	sold	Premium	Premium	Premium	CEO & President

DYN - Dyne Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for DYN